Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by rollthedice10on Dec 01, 2024 12:04pm
210 Views
Post# 36339601

RE:RE:Pioneering is never easy...

RE:RE:Pioneering is never easy...Yes it looks like things are well in hand and progressing. TLT is obviously
known to FDA and is actively working with them. Another poster suggests
writing JFK jr etc about TLT. I don't think that is a good idea at all. Things are
in motion and blindly throwing wrenches into the works could backfire spectacularly.
I say leave it alone and don't mess with it even if intentions are good. I think we are 
very close to BTD and I would hate to see that sidelined by unsolicitated noise from
shareholders of TLT. We just don't know the lay of the land at the FDA and it would
not be wise to stumble into that possible minefield. I know not everyone will agree
with me but that's ok. JMHO.
<< Previous
Bullboard Posts
Next >>